LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers

Triple-negative breast cancers (TNBCs) account for a large proportion of breast cancer deaths, due to the high rate of recurrence from residual, resistant tumor cells. New treatments are needed, to bypass chemoresistance and improve survival. The WNT pathway, which is activated in TNBCs, has been id...

Descripción completa

Detalles Bibliográficos
Autores principales: Maubant, Sylvie, Tahtouh, Tania, Brisson, Amélie, Maire, Virginie, Némati, Fariba, Tesson, Bruno, Ye, Mengliang, Rigaill, Guillem, Noizet, Maïté, Dumont, Aurélie, Gentien, David, Marty-Prouvost, Bérengère, de Koning, Leanne, Mahmood, Sardar Faisal, Decaudin, Didier, Cruzalegui, Francisco, Tucker, Gordon C., Roman-Roman, Sergio, Dubois, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978250/
https://www.ncbi.nlm.nih.gov/pubmed/29854300
http://dx.doi.org/10.18632/oncotarget.25187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978250/
https://www.ncbi.nlm.nih.gov/pubmed/29854300
http://dx.doi.org/10.18632/oncotarget.25187

Ejemplares similares